Skip To The Main Content

Press Releases

  • PDA Names Robert L. Dana Sr. Vice President for Regulatory Affairs and PDA TRI

    2/1/2009 5:00:00 AM
    In January 2009, Robert L. Dana, a long time PDA member, assumed new responsibilities within PDA. In his new role as Senior Vice President, Regulatory Affairs and Training and Research Institute, he will report to Bob Myers, President of PDA, and will also maintain a dotted line relationship to Rich Levy, PhD, Sr. VP, Scientific and Regulatory Affairs, PDA and will continue to serve as PDA’s regulatory authority.
  • PDA’s Library of Filtration Best Practices Grows Stronger with Revised TR-26 and TR-41

    2/20/2009 7:47:00 PM
    PDA members who work with sterilizing and viral filters will benefit from updated best practices included in the 2008 revisions of PDA Technical Report No. 26, Sterilizing Filtration of Liquids and Technical Report No. 41, Virus Filtration.
  • PDA and HighWire Press Launch Project for Online PDA Journal

    3/20/2009 6:47:00 PM
    PDA and HighWire Press officially began a partnership to create a new, modern online experience for the readers of its 63-year-old PDA Journal of Pharmaceutical Science and Technology.
  • PDA Comments on the U.S. FDA’s Draft Guidance on Process Validation

    3/23/2009 6:47:00 PM
    The public comment period for the U.S. FDA’s draft guidance on process validation generated more activity from PDA members since the Agency published its aseptic guidance for comment earlier in the decade. More than 400 comments were submitted to PDA, which established an online tool to collect the comments.
  • PDA/FDA Joint Regulatory Conference Keynote Speakers Look Ahead to 2020

    5/8/2009 6:47:00 PM
    The Parenteral Drug Association (PDA) has confirmed three keynote speakers for the 2009 PDA/FDA Joint Regulatory Conference who will discuss what the year 2020 will look like for the industry and what challenges must be overcome for the pharmaceutical industry, especially in the manufacturing segment of the industry.
  • PDA Israel Chapter to host two PDA TRI courses in July

    5/21/2009 6:47:00 PM
    The Parenteral Drug Association Training and Research Institute (PDA TRI) and the PDA Israel Chapter are teaming up this July to bring the Institute’s world-class training for the pharmaceutical/biopharmaceutical industry to Israel, with two courses covering regulatory hot topics.
  • PDA and PDA Taiwan Chapter Ink Deal for Closer Collaboration

    5/26/2009 6:47:00 PM
    The Parenteral Drug Association (PDA) reached a membership and information-sharing agreement with its chapter in Taiwan, which closely supports the Taiwan FDA (TFDA).
  • SIFDS/PDA Shanghai Joint Development Center Unveils Office

    6/30/2009 8:15:00 AM
    Officials from the Shanghai Institute of Food and Drug Safety (SIFDS), a branch of the Shanghai Municipal Food and Drug Administration (SHFDA), and the Parenteral Drug Association, Inc. (PDA) celebrated the grand opening of a new office for the SIFDS/PDA Joint Development Center (SHJDC).
  • Perspective on Regulations from an Insider to Close the 2009 PDA/FDA Meeting

    7/10/2009 4:00:00 AM
    Something unique to the long-running PDA/FDA Joint Regulatory Conference will occur this year. Not only will the meeting delve deeply into the most pressing regulatory issues of the day, but its closing day will include a powerful reality check when regulatory affairs professional and breast cancer survivor Amy Giertych provides her unique perspective as both an insider and a patient.
  • Richard M. Johnson Named PDA President

    8/26/2009 6:15:00 PM
    The Parenteral Drug Association, Inc. (PDA) has announced the appointment of Richard M. Johnson as the Association’s next President, effective September 2009.
  • U.S. FDA Deputy Commissioner Outlines Principles in Keynote Address at PDA/FDA Meeting

    9/23/2009 6:15:00 PM
    U.S. FDA Deputy Commissioner Joshua Sharfstein, MD, previewed what direction the Agency’s public health policies will take under new Commissioner Margaret Hamburg, MD, during his keynote address at the 2009 PDA/FDA Joint Regulatory Meeting in Washington, D.C. on September 14.
  • New Book on Environmental Monitoring Grows PDA’s Library of Technical Information

    10/2/2009 4:00:00 AM
    The Parenteral Drug Association (PDA) and DHI books have published volume three of Environmental Monitoring: A Comprehensive Handbook.
  • European Health Authorities Tell Pharma Companies to Reinforce Supply Chains, Put Patients First

    10/23/2009 6:15:00 PM
    Berlin (October 23, 2009) – The European Medicines Agency (EMEA) told industry manufacturing, control and regulatory professionals gathered at the 2009 PDA/EMEA Joint Conference that complicated supply chains, while necessary, are a weak link in quality control.
  • Editor Bill Paulson to Become International Pharmaceutical Quality (IPQ) Publisher

    11/9/2009 7:15:00 PM
    In mid-November, PDA is turning over the publishing responsibilities for IPQ to Bill Paulson, who will continue to provide IPQ to PDA members on a complimentary basis for an interim period while subscription, site licensing and sponsorship opportunities are being pursued.
  • NASA Spaceflight Expert Confirmed Keynote Speaker for 2010 PDA Annual Meeting

    12/14/2009 5:00:00 AM
    The Parenteral Drug Association (PDA) has confirmed that Janice V. Meck, PhD, Director, Cardiovascular Laboratory, NASA-Johnson Space Center will present "Development of a Pharmaceutical Countermeasure for Post-spaceflight Orthostatic Intolerance" during the Opening Plenary Session of the 2010 PDA Annual Meeting.